BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
294 results:

  • 1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
    Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
    Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
    Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK.
    Evans I; Reisel D; Jones A; Bajrami A; Nijjar S; Solangon SA; Arora R; Redl E; Schreiberhuber L; Ishaq-Parveen I; Rothärmel J; Herzog C; Jurkovic D; Widschwendter M
    Lancet Oncol; 2023 Dec; 24(12):1375-1386. PubMed ID: 37944542
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients.
    Bolaños-Suárez V; Alfaro A; Espinosa AM; Medina-Martínez I; Juárez E; Villegas-Sepúlveda N; Gudiño-Zayas M; Gutiérrez-Castro A; Román-Bassaure E; Salinas-Nieves ME; Bruno-Muñoz S; Aranda C; Flores-Herrera O; Berumen J
    Cancer Med; 2023 Jul; 12(14):15632-15649. PubMed ID: 37326348
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study.
    Reijnen C; Vrede SW; Eijkelenboom A; Draak R; Sweegers S; Snijders MPLM; van Gestel P; Pijnenborg JMA; Bulten J; Küsters-Vandevelde HVN
    Cancer Med; 2023 Jun; 12(11):12365-12376. PubMed ID: 37081760
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
    Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
    Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma.
    Madariaga A; Garg S; Tchrakian N; Dhani NC; Jimenez W; Welch S; MacKay H; Ethier JL; Gilbert L; Li X; Rodriguez A; Chan L; Bowering V; Clarke B; Zhang T; King I; Downs G; Stockley T; Wang L; Udagani S; Oza AM; Lheureux S
    Nat Commun; 2023 Mar; 14(1):1452. PubMed ID: 36922497
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effects of Fractionated Radiation Exposure on Vimentin Expression in Cervical cancers: Analysis of Association with cancer Stem Cell Response and Short-Term Prognosis.
    Zamulaeva I; Matchuk O; Selivanova E; Mkrtchian L; Yakimova A; Gusarova V; Lipunov N; Krikunova L; Ivanov S; Kaprin A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834676
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. clinical outcome analysis of intramural myoma greater than 8 cm in diameter removed during caesarean section: a retrospective study.
    Shi C; Chen J; Chen A
    BMC Womens Health; 2023 Feb; 23(1):60. PubMed ID: 36774454
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T-cell infiltration.
    Wang X; Fang A; Peng Y; Yu J; Yu C; Xie J; Zheng Y; Song L; Li P; Li J; Kang X; Lin Y; Li W
    J Cell Mol Med; 2023 Mar; 27(5):609-621. PubMed ID: 36756714
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Unilateral uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids-Experience in a Case Series.
    Pyra K; Szmygin M; Szmygin H; Woźniak S; Jargiełło T
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556934
    [No Abstract]    [Full Text] [Related]  

  • 13. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
    Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
    Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
    Kok HP; Herrera TD; Crezee J
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):994-1003. PubMed ID: 36288756
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
    Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience.
    Kim MS; Jeong SY; Lee YY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):333-338. PubMed ID: 35361397
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy.
    Javed S; Sood S; Rai B; Bhattacharyya S; Bagga R; Srinivasan R
    Indian J Med Res; 2021 Aug; 154(2):367-374. PubMed ID: 35295009
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effects of steroid use for stenosis prevention after endoscopic submucosal dissection for cervical esophageal cancer.
    Muroi K; Kakushima N; Furukawa K; Furune S; Ito N; Hirose T; Ishikawa E; Mizutani Y; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Funasaka K; Miyahara R; Fujishiro M
    Int J Clin Oncol; 2022 May; 27(5):940-947. PubMed ID: 35194703
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. "Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping".
    Jebens Nordskar N; Hagen B; V Vesterfjell E; Salvesen Ø; Aune G
    Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():77-82. PubMed ID: 35151960
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Preoperative high-dose-rate brachytherapy for high-risk early-stage cervical cancer: Long-term clinical outcome analysis.
    Gauci PA; Kee DLC; Thamphya B; Schiappa R; Delotte J; Chand-Fouche ME; Hannoun-Levi JM
    Brachytherapy; 2022; 21(3):273-282. PubMed ID: 35094933
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.